Results 1 to 10 of about 101,079 (312)

Development of an eHealth Intervention in Pediatric Home Infusion Therapy: Interview Study of Needs and Preferences of Parents and Health Care Professionals [PDF]

open access: yesJMIR Pediatrics and Parenting
BackgroundWith the provision of home infusion therapy in children with acute or long-term illness on the rise, eHealth technologies have the potential to bridge the transition between hospital and home.
Helena Hansson   +4 more
doaj   +2 more sources

Transforming long-term post-acute care for the aging population through home infusion therapy in China: assurance for quality and safety of care delivery (Part 2) [PDF]

open access: yesFrontiers in Public Health
BackgroundChina's healthcare system may benefit from the integration of home infusion therapy (HIT) combined with home health services (HHS) to address the urgent need for a sustainable long-term, post-acute care model for the aging population and those ...
Wei Zuo   +23 more
doaj   +2 more sources

Safety of home administration of cipaglucosidase alfa plus miglustat in late-onset Pompe disease: results from multiple clinical trials [PDF]

open access: yesTherapeutic Advances in Rare Disease
Background: Late-onset Pompe disease (LOPD) is caused by a deficiency of the acid α-glucosidase enzyme. In LOPD treatment, enzyme replacement therapy is delivered via intravenous infusion, typically in clinical settings. Cipaglucosidase alfa is delivered
Henning Andersen   +11 more
doaj   +2 more sources

Transforming long-term post-acute care for the aging population through home infusion therapy in China: an assessment of need and demand (Part 1) [PDF]

open access: yesFrontiers in Public Health
BackgroundChina’s healthcare system is confronting a rising burden of antimicrobial resistance, chronic complex diseases, and an aging population requiring long-term, post-acute care.
Wei Zuo   +24 more
doaj   +2 more sources

Managing Home Infusion Therapy [PDF]

open access: yesAJN, American Journal of Nursing, 2020
This article is part of a series, Supporting Family Caregivers: No Longer Home Alone, published in collaboration with the AARP Public Policy Institute. Results of focus groups, conducted as part of the AARP Public Policy Institute's No Longer Home Alone video project, supported evidence that family caregivers aren't given the information they need to ...
Bronwyn E, Fields   +2 more
openaire   +2 more sources

Controlling the chaos: Information management in home-infusion central-line–associated bloodstream infection (CLABSI) surveillance

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology, 2023
Objectives: Access to patient information may affect how home-infusion surveillance staff identify central-line–associated bloodstream infections (CLABSIs). We characterized information hazards in home-infusion CLABSI surveillance and identified possible
Susan M. Hannum   +9 more
doaj   +1 more source

Home Albumin Infusion Therapy, Another Alternative Treatment in Patients With Congenital Nephrotic Syndrome of the Finnish Type

open access: yesFrontiers in Pediatrics, 2021
Background: Congenital nephrotic syndrome of the Finnish type (CNF) is a rare, severe glomerular disease caused by mutations in the NPHS1 gene, which codes for nephrin. It is characterised by massive proteinuria and severe edoema.
Eugènia Serramontmany   +6 more
doaj   +1 more source

Current Practices and Opportunities for Outpatient Parenteral Antimicrobial Therapy in Hospitals: A National Cross-Sectional Survey

open access: yesAntibiotics, 2022
This nationwide study assessed how outpatient parenteral antimicrobial therapy (OPAT) is organised by Dutch acute care hospitals, the barriers experienced, and how an OPAT program affects the way hospitals organised OPAT care. We systematically developed
Hester H. Stoorvogel   +6 more
doaj   +1 more source

Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study

open access: yesOrphanet Journal of Rare Diseases, 2023
Background Pompe disease is a lysosomal storage disease treated with life-long enzyme replacement therapy (ERT). Home-based ERT has been provided in the Netherlands since 2008 because it diminishes the burden of treatment, increases patient flexibility ...
Imke A. M. Ditters   +5 more
doaj   +1 more source

Time spent at home among older adults with acute myeloid leukemia receiving azacitidine- or venetoclax-based regimens

open access: yesHaematologica, 2022
Time at home is a critically important outcome to adults with acute myeloid leukemia (AML) when selecting treatment; however, no study to date has adequately described the amount of time older adults spend at home following initiation of chemotherapy ...
Christopher E. Jensen   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy